Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Financial Flexibility Index
Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Financial Flexibility Index of -0.95x as of September 2025. Free cash flow of $-18.60 Million (operating CF $-19.20 Million minus capex $600.00K) represents -1% of total liabilities ($19.64 Million). Also explore ARTV net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Artiva Biotherapeutics, Inc. Common Stock Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Artiva Biotherapeutics, Inc. Common Stock across 5 annual periods. Check ARTV capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Artiva Biotherapeutics, Inc. Common Stock (2020–2024)
Year-by-year free cash flow to debt coverage for Artiva Biotherapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see how much is Artiva Biotherapeutics, Inc. Common Stoc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-54.39 Million | $-55.03 Million | $22.94 Million | ▼ -1333.8% |
| 2023 | -0.17x | $-44.17 Million | $-47.43 Million | $267.13 Million | ▼ -1.7% |
| 2022 | -0.16x | $-44.53 Million | $-50.83 Million | $273.75 Million | ▼ -210.0% |
| 2021 | -0.05x | $-13.58 Million | $-15.30 Million | $258.78 Million | ▲ +79.9% |
| 2020 | -0.26x | $-13.26 Million | $-13.54 Million | $50.80 Million | — |